Wellpartner provides contract pharmacy administration and pharmacy distribution solutions that allow qualifying “safety-net” hospitals to qualify and access prescriptions for medications at a lower cost.
The company helps US hospitals better manage their 340B discounted drugs programme for Medicaid patients resulting in their ability to better support their community, serve more patients and provide other needed services. Wellpartner is fully compliant with State and Federal laws with regards to all aspects of medication handling.
During the course of Apposite’s investment, the company significantly grew its contract pharmacy SaaS business, further diversified its pharmacy services, and completed three strategic acquisitions. By time of exit, revenues grew by 89%, became highly profitable and had repaid all outstanding debt facilities.
The company was sold to a strategic buyer via an auction sale process in November 2017.